Mino (Minocycline)

Minocycline belongs to the tetracycline class and exerts its antibacterial effect by binding to the 30S subunit of bacterial ribosomes. This binding blocks the attachment of aminoacyl‑tRNA, preventing the addition of new amino acids to the peptide chain and thereby halting bacterial protein synthesis. The result is a bacteriostatic action against susceptible organisms.

The dosage of Mino (Minocycline) is determined by the prescribing clinician based on the specific infection, patient age, weight, renal and hepatic function, and other clinical factors. Healthcare professionals tailor the regimen to achieve optimal therapeutic outcomes while minimizing potential adverse effects.

Safety data for minocycline in pregnancy and lactation are limited. The drug is generally avoided during pregnancy, especially in the second and third trimesters, due to potential risks to the fetus, such as tooth discoloration. Breastfeeding mothers should consult their healthcare provider, as minocycline can be excreted in breast milk and may affect the infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Mino. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After receiving the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements), and assist with import documentation.

Minocycline offers a longer half‑life and better tissue penetration than earlier tetracyclines such as doxycycline, allowing once‑ or twice‑daily dosing. It also has a broader spectrum against certain resistant strains. However, it may cause more vestibular side effects and has a higher risk of pigmentary changes. Choice of therapy depends on the infection type, patient tolerance, and resistance patterns.

Mino (Minocycline) should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid environments such as bathrooms.

Mino is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should avoid concurrent intake of antacids, calcium, magnesium or iron supplements, as these can reduce absorption. Swallow tablets whole; do not crush or chew unless specifically instructed by a healthcare professional.

Serious adverse reactions include Stevens‑Johnson syndrome, toxic epidermal necrolysis, drug‑induced hepatitis, pseudotumor cerebri, and severe blood dyscrasias such as agranulocytosis. Patients should seek immediate medical attention if they develop rash, fever, jaundice, severe headache, visual changes, or unexplained bruising or bleeding.

Mino is contraindicated in patients with known hypersensitivity to minocycline or other tetracyclines, in children younger than 8 years due to risk of permanent tooth discoloration, and in pregnant women unless clearly needed. Caution is also advised for individuals with severe hepatic or renal impairment, and those taking interacting medications such as isotretinoin or certain anticoagulants.